Effect of pre-reperfusion SGLT2 Inhibitors on infarct size and ventricular function in patients with acute myocardial infarction

11 December 2025 (08:00 - 15:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Nabhat Noparatkailas

Faculty of Medicine, Chiang Mai University, Chiang Mai (Thailand)

5 More presentations in this session

Presentation thumbnail

The rupture risk triad: a novel cardiac magnetic resonance-based predictor of impending heart rupture after STEMI

Doctor L. Fulceri (Pisa, IT)

Abstract Slides

Presentation thumbnail

Effects of RAFF2 periodicity enhance the contrast between sub-chronic myocardial infarction and remote myocardium

Mr E. Yla-Herttuala (Kuopio, FI)

Abstract Slides

Presentation thumbnail

Cardiovascular magnetic resonance-derived left atrial function and left ventricular remodelling after reperfused anterior ST-elevation myocardial infarction

Mr B. Yosofi (Nijmegen, NL)

Abstract Slides

Presentation thumbnail

Impact of first myocardial infarction on the right ventricle: a magnetic resonance-based assessment

Doctor C. Borguezan Daros (Harefield, Uxbridge, GB)

Abstract Slides

Presentation thumbnail

The long-term predictive value of myocardial deformation measurement with cardiac magnetic resonance in acute myocardial infarction

Doctor W. El-Saadi (Jonkoping, SE)

Abstract Slides

Access the full session

Session thumbnail

Left, right, and remote: ventricular and atrial CMR biomarkers after MI

The Event

Event poster

EACVI 2025

11 December - 13 December 2025

You may be interested in

Congress Presentation

CMR in acute coronary syndrome: optional or essential? - discussion

Congress Presentation

Late gadolinium enhancement and viability

Congress Presentation

Magnetic resonance imaging is the way to go for risk assessment

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources